BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30084646)

  • 1. Adherence to and Persistence With Statin Therapy in a Veteran Population.
    Morotti K; Lopez J; Vaupel V; Swislocki A; Siegel D
    Ann Pharmacother; 2019 Jan; 53(1):43-49. PubMed ID: 30084646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2019 Mar; 4(3):206-213. PubMed ID: 30758506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
    Watanabe JH; Kazerooni R; Bounthavong M
    J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System.
    Lucas JE; Bazemore TC; Alo C; Monahan PB; Voora D
    PLoS One; 2017; 12(11):e0187809. PubMed ID: 29155848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan.
    Chen ST; Huang ST; Shau WY; Lai CL; Li JZ; Fung S; Tse VC; Lai MS
    BMC Cardiovasc Disord; 2019 Mar; 19(1):62. PubMed ID: 30876393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study.
    Watanabe JH; Bounthavong M; Chen T; Ney JP
    Ann Pharmacother; 2013 Oct; 47(10):1253-9. PubMed ID: 24259688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands.
    Alfian SD; Worawutputtapong P; Schuiling-Veninga CCM; van der Schans J; Bos JHJ; Hak E; Denig P
    Curr Med Res Opin; 2018 Jun; 34(6):1013-1019. PubMed ID: 29292657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].
    Degli Esposti L; Sangiorgi D; Arca M; Vigna GB; Budal S; Degli Esposti E
    Monaldi Arch Chest Dis; 2011 Dec; 76(4):160-7. PubMed ID: 22567731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics.
    Pedan A; Varasteh L; Schneeweiss S
    J Manag Care Pharm; 2007; 13(6):487-96. PubMed ID: 17672810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
    Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
    Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia.
    Casula M; Scotti L; Tragni E; Merlino L; Corrao G; Catapano AL
    Atherosclerosis; 2016 Nov; 254():172-178. PubMed ID: 27750108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy.
    Brinton EA
    Clin Cardiol; 2018 Jun; 41(6):710-720. PubMed ID: 29749101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    Herttua K; Martikainen P; Batty GD; Kivimäki M
    J Am Coll Cardiol; 2016 Apr; 67(13):1507-1515. PubMed ID: 27150680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy.
    Benner JS; Pollack MF; Smith TW; Bullano MF; Willey VJ; Williams SA
    Am J Health Syst Pharm; 2005 Jul; 62(14):1468-75. PubMed ID: 15998926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.